Global Ophthalmic Disease Therapeutic Supply, Demand and Key Producers, 2023-2029
The global Ophthalmic Disease Therapeutic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Ophthalmic Disease Therapeutic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ophthalmic Disease Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ophthalmic Disease Therapeutic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ophthalmic Disease Therapeutic total market, 2018-2029, (USD Million)
Global Ophthalmic Disease Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Ophthalmic Disease Therapeutic total market, key domestic companies and share, (USD Million)
Global Ophthalmic Disease Therapeutic revenue by player and market share 2018-2023, (USD Million)
Global Ophthalmic Disease Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)
Global Ophthalmic Disease Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Ophthalmic Disease Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals, AbbVie Inc, Santen Pharmaceutical Co. Ltd., Novartis AG, Bayer AG, F. Hoffmann-La Roche and Viatris Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ophthalmic Disease Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Ophthalmic Disease Therapeutic Market, By Region:
1. How big is the global Ophthalmic Disease Therapeutic market?
2. What is the demand of the global Ophthalmic Disease Therapeutic market?
3. What is the year over year growth of the global Ophthalmic Disease Therapeutic market?
4. What is the total value of the global Ophthalmic Disease Therapeutic market?
5. Who are the major players in the global Ophthalmic Disease Therapeutic market?
6. What are the growth factors driving the market demand?
This report studies the global Ophthalmic Disease Therapeutic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ophthalmic Disease Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ophthalmic Disease Therapeutic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ophthalmic Disease Therapeutic total market, 2018-2029, (USD Million)
Global Ophthalmic Disease Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Ophthalmic Disease Therapeutic total market, key domestic companies and share, (USD Million)
Global Ophthalmic Disease Therapeutic revenue by player and market share 2018-2023, (USD Million)
Global Ophthalmic Disease Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)
Global Ophthalmic Disease Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Ophthalmic Disease Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals, AbbVie Inc, Santen Pharmaceutical Co. Ltd., Novartis AG, Bayer AG, F. Hoffmann-La Roche and Viatris Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ophthalmic Disease Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Ophthalmic Disease Therapeutic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Anti-inflammatory
- Anti-infectives
- Anti-VEGF
- Anti-glaucoma
- Glaucoma
- Dry Eye Disease
- Retinal Diseases
- Allergy & Infections
- Regeneron Pharmaceuticals
- AbbVie Inc
- Santen Pharmaceutical Co. Ltd.
- Novartis AG
- Bayer AG
- F. Hoffmann-La Roche
- Viatris Inc.
1. How big is the global Ophthalmic Disease Therapeutic market?
2. What is the demand of the global Ophthalmic Disease Therapeutic market?
3. What is the year over year growth of the global Ophthalmic Disease Therapeutic market?
4. What is the total value of the global Ophthalmic Disease Therapeutic market?
5. Who are the major players in the global Ophthalmic Disease Therapeutic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Ophthalmic Disease Therapeutic Introduction
1.2 World Ophthalmic Disease Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Ophthalmic Disease Therapeutic Total Market by Region (by Headquarter Location)
1.3.1 World Ophthalmic Disease Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.3 China Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.4 Europe Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.5 Japan Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.6 South Korea Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.7 ASEAN Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.8 India Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ophthalmic Disease Therapeutic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ophthalmic Disease Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.2 World Ophthalmic Disease Therapeutic Consumption Value by Region
2.2.1 World Ophthalmic Disease Therapeutic Consumption Value by Region (2018-2023)
2.2.2 World Ophthalmic Disease Therapeutic Consumption Value Forecast by Region (2024-2029)
2.3 United States Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.4 China Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.5 Europe Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.6 Japan Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.7 South Korea Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.8 ASEAN Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.9 India Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
3 WORLD OPHTHALMIC DISEASE THERAPEUTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Ophthalmic Disease Therapeutic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Ophthalmic Disease Therapeutic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Ophthalmic Disease Therapeutic in 2022
3.2.3 Global Concentration Ratios (CR8) for Ophthalmic Disease Therapeutic in 2022
3.3 Ophthalmic Disease Therapeutic Company Evaluation Quadrant
3.4 Ophthalmic Disease Therapeutic Market: Overall Company Footprint Analysis
3.4.1 Ophthalmic Disease Therapeutic Market: Region Footprint
3.4.2 Ophthalmic Disease Therapeutic Market: Company Product Type Footprint
3.4.3 Ophthalmic Disease Therapeutic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Ophthalmic Disease Therapeutic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Ophthalmic Disease Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Ophthalmic Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Ophthalmic Disease Therapeutic Consumption Value Comparison
4.2.1 United States VS China: Ophthalmic Disease Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Ophthalmic Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Ophthalmic Disease Therapeutic Companies and Market Share, 2018-2023
4.3.1 United States Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
4.4 China Based Companies Ophthalmic Disease Therapeutic Revenue and Market Share, 2018-2023
4.4.1 China Based Ophthalmic Disease Therapeutic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
4.5 Rest of World Based Ophthalmic Disease Therapeutic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Ophthalmic Disease Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Anti-inflammatory
5.2.2 Anti-infectives
5.2.3 Anti-VEGF
5.2.4 Anti-glaucoma
5.3 Market Segment by Type
5.3.1 World Ophthalmic Disease Therapeutic Market Size by Type (2018-2023)
5.3.2 World Ophthalmic Disease Therapeutic Market Size by Type (2024-2029)
5.3.3 World Ophthalmic Disease Therapeutic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ophthalmic Disease Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Glaucoma
6.2.2 Dry Eye Disease
6.2.3 Retinal Diseases
6.2.4 Allergy & Infections
6.2.5 Allergy & Infections
6.3 Market Segment by Application
6.3.1 World Ophthalmic Disease Therapeutic Market Size by Application (2018-2023)
6.3.2 World Ophthalmic Disease Therapeutic Market Size by Application (2024-2029)
6.3.3 World Ophthalmic Disease Therapeutic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Regeneron Pharmaceuticals
7.1.1 Regeneron Pharmaceuticals Details
7.1.2 Regeneron Pharmaceuticals Major Business
7.1.3 Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Product and Services
7.1.4 Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.1.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.2 AbbVie Inc
7.2.1 AbbVie Inc Details
7.2.2 AbbVie Inc Major Business
7.2.3 AbbVie Inc Ophthalmic Disease Therapeutic Product and Services
7.2.4 AbbVie Inc Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Inc Recent Developments/Updates
7.2.6 AbbVie Inc Competitive Strengths & Weaknesses
7.3 Santen Pharmaceutical Co. Ltd.
7.3.1 Santen Pharmaceutical Co. Ltd. Details
7.3.2 Santen Pharmaceutical Co. Ltd. Major Business
7.3.3 Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Product and Services
7.3.4 Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Santen Pharmaceutical Co. Ltd. Recent Developments/Updates
7.3.6 Santen Pharmaceutical Co. Ltd. Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Ophthalmic Disease Therapeutic Product and Services
7.4.4 Novartis AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Bayer AG
7.5.1 Bayer AG Details
7.5.2 Bayer AG Major Business
7.5.3 Bayer AG Ophthalmic Disease Therapeutic Product and Services
7.5.4 Bayer AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bayer AG Recent Developments/Updates
7.5.6 Bayer AG Competitive Strengths & Weaknesses
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Details
7.6.2 F. Hoffmann-La Roche Major Business
7.6.3 F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Product and Services
7.6.4 F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 F. Hoffmann-La Roche Recent Developments/Updates
7.6.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.7 Viatris Inc.
7.7.1 Viatris Inc. Details
7.7.2 Viatris Inc. Major Business
7.7.3 Viatris Inc. Ophthalmic Disease Therapeutic Product and Services
7.7.4 Viatris Inc. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Inc. Recent Developments/Updates
7.7.6 Viatris Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ophthalmic Disease Therapeutic Industry Chain
8.2 Ophthalmic Disease Therapeutic Upstream Analysis
8.3 Ophthalmic Disease Therapeutic Midstream Analysis
8.4 Ophthalmic Disease Therapeutic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Ophthalmic Disease Therapeutic Introduction
1.2 World Ophthalmic Disease Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Ophthalmic Disease Therapeutic Total Market by Region (by Headquarter Location)
1.3.1 World Ophthalmic Disease Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.3 China Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.4 Europe Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.5 Japan Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.6 South Korea Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.7 ASEAN Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.3.8 India Ophthalmic Disease Therapeutic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ophthalmic Disease Therapeutic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ophthalmic Disease Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.2 World Ophthalmic Disease Therapeutic Consumption Value by Region
2.2.1 World Ophthalmic Disease Therapeutic Consumption Value by Region (2018-2023)
2.2.2 World Ophthalmic Disease Therapeutic Consumption Value Forecast by Region (2024-2029)
2.3 United States Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.4 China Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.5 Europe Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.6 Japan Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.7 South Korea Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.8 ASEAN Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
2.9 India Ophthalmic Disease Therapeutic Consumption Value (2018-2029)
3 WORLD OPHTHALMIC DISEASE THERAPEUTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Ophthalmic Disease Therapeutic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Ophthalmic Disease Therapeutic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Ophthalmic Disease Therapeutic in 2022
3.2.3 Global Concentration Ratios (CR8) for Ophthalmic Disease Therapeutic in 2022
3.3 Ophthalmic Disease Therapeutic Company Evaluation Quadrant
3.4 Ophthalmic Disease Therapeutic Market: Overall Company Footprint Analysis
3.4.1 Ophthalmic Disease Therapeutic Market: Region Footprint
3.4.2 Ophthalmic Disease Therapeutic Market: Company Product Type Footprint
3.4.3 Ophthalmic Disease Therapeutic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Ophthalmic Disease Therapeutic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Ophthalmic Disease Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Ophthalmic Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Ophthalmic Disease Therapeutic Consumption Value Comparison
4.2.1 United States VS China: Ophthalmic Disease Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Ophthalmic Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Ophthalmic Disease Therapeutic Companies and Market Share, 2018-2023
4.3.1 United States Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
4.4 China Based Companies Ophthalmic Disease Therapeutic Revenue and Market Share, 2018-2023
4.4.1 China Based Ophthalmic Disease Therapeutic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
4.5 Rest of World Based Ophthalmic Disease Therapeutic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Ophthalmic Disease Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Anti-inflammatory
5.2.2 Anti-infectives
5.2.3 Anti-VEGF
5.2.4 Anti-glaucoma
5.3 Market Segment by Type
5.3.1 World Ophthalmic Disease Therapeutic Market Size by Type (2018-2023)
5.3.2 World Ophthalmic Disease Therapeutic Market Size by Type (2024-2029)
5.3.3 World Ophthalmic Disease Therapeutic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ophthalmic Disease Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Glaucoma
6.2.2 Dry Eye Disease
6.2.3 Retinal Diseases
6.2.4 Allergy & Infections
6.2.5 Allergy & Infections
6.3 Market Segment by Application
6.3.1 World Ophthalmic Disease Therapeutic Market Size by Application (2018-2023)
6.3.2 World Ophthalmic Disease Therapeutic Market Size by Application (2024-2029)
6.3.3 World Ophthalmic Disease Therapeutic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Regeneron Pharmaceuticals
7.1.1 Regeneron Pharmaceuticals Details
7.1.2 Regeneron Pharmaceuticals Major Business
7.1.3 Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Product and Services
7.1.4 Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.1.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.2 AbbVie Inc
7.2.1 AbbVie Inc Details
7.2.2 AbbVie Inc Major Business
7.2.3 AbbVie Inc Ophthalmic Disease Therapeutic Product and Services
7.2.4 AbbVie Inc Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Inc Recent Developments/Updates
7.2.6 AbbVie Inc Competitive Strengths & Weaknesses
7.3 Santen Pharmaceutical Co. Ltd.
7.3.1 Santen Pharmaceutical Co. Ltd. Details
7.3.2 Santen Pharmaceutical Co. Ltd. Major Business
7.3.3 Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Product and Services
7.3.4 Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Santen Pharmaceutical Co. Ltd. Recent Developments/Updates
7.3.6 Santen Pharmaceutical Co. Ltd. Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Ophthalmic Disease Therapeutic Product and Services
7.4.4 Novartis AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 Bayer AG
7.5.1 Bayer AG Details
7.5.2 Bayer AG Major Business
7.5.3 Bayer AG Ophthalmic Disease Therapeutic Product and Services
7.5.4 Bayer AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bayer AG Recent Developments/Updates
7.5.6 Bayer AG Competitive Strengths & Weaknesses
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Details
7.6.2 F. Hoffmann-La Roche Major Business
7.6.3 F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Product and Services
7.6.4 F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 F. Hoffmann-La Roche Recent Developments/Updates
7.6.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.7 Viatris Inc.
7.7.1 Viatris Inc. Details
7.7.2 Viatris Inc. Major Business
7.7.3 Viatris Inc. Ophthalmic Disease Therapeutic Product and Services
7.7.4 Viatris Inc. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Inc. Recent Developments/Updates
7.7.6 Viatris Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ophthalmic Disease Therapeutic Industry Chain
8.2 Ophthalmic Disease Therapeutic Upstream Analysis
8.3 Ophthalmic Disease Therapeutic Midstream Analysis
8.4 Ophthalmic Disease Therapeutic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Ophthalmic Disease Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Ophthalmic Disease Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Ophthalmic Disease Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Ophthalmic Disease Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Ophthalmic Disease Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Ophthalmic Disease Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Ophthalmic Disease Therapeutic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Ophthalmic Disease Therapeutic Players in 2022
Table 12. World Ophthalmic Disease Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Ophthalmic Disease Therapeutic Company Evaluation Quadrant
Table 14. Head Office of Key Ophthalmic Disease Therapeutic Player
Table 15. Ophthalmic Disease Therapeutic Market: Company Product Type Footprint
Table 16. Ophthalmic Disease Therapeutic Market: Company Product Application Footprint
Table 17. Ophthalmic Disease Therapeutic Mergers & Acquisitions Activity
Table 18. United States VS China Ophthalmic Disease Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Ophthalmic Disease Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 23. China Based Ophthalmic Disease Therapeutic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 29. World Ophthalmic Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Ophthalmic Disease Therapeutic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Ophthalmic Disease Therapeutic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Ophthalmic Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Ophthalmic Disease Therapeutic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Ophthalmic Disease Therapeutic Market Size by Application (2024-2029) & (USD Million)
Table 35. Regeneron Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Regeneron Pharmaceuticals Major Business
Table 37. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Product and Services
Table 38. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Regeneron Pharmaceuticals Recent Developments/Updates
Table 40. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. AbbVie Inc Basic Information, Area Served and Competitors
Table 42. AbbVie Inc Major Business
Table 43. AbbVie Inc Ophthalmic Disease Therapeutic Product and Services
Table 44. AbbVie Inc Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AbbVie Inc Recent Developments/Updates
Table 46. AbbVie Inc Competitive Strengths & Weaknesses
Table 47. Santen Pharmaceutical Co. Ltd. Basic Information, Area Served and Competitors
Table 48. Santen Pharmaceutical Co. Ltd. Major Business
Table 49. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Product and Services
Table 50. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Santen Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 52. Santen Pharmaceutical Co. Ltd. Competitive Strengths & Weaknesses
Table 53. Novartis AG Basic Information, Area Served and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Ophthalmic Disease Therapeutic Product and Services
Table 56. Novartis AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Novartis AG Competitive Strengths & Weaknesses
Table 59. Bayer AG Basic Information, Area Served and Competitors
Table 60. Bayer AG Major Business
Table 61. Bayer AG Ophthalmic Disease Therapeutic Product and Services
Table 62. Bayer AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bayer AG Recent Developments/Updates
Table 64. Bayer AG Competitive Strengths & Weaknesses
Table 65. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 66. F. Hoffmann-La Roche Major Business
Table 67. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Product and Services
Table 68. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. F. Hoffmann-La Roche Recent Developments/Updates
Table 70. Viatris Inc. Basic Information, Area Served and Competitors
Table 71. Viatris Inc. Major Business
Table 72. Viatris Inc. Ophthalmic Disease Therapeutic Product and Services
Table 73. Viatris Inc. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Ophthalmic Disease Therapeutic Upstream (Raw Materials)
Table 75. Ophthalmic Disease Therapeutic Typical Customers
Table 1. World Ophthalmic Disease Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Ophthalmic Disease Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Ophthalmic Disease Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Ophthalmic Disease Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Ophthalmic Disease Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Ophthalmic Disease Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Ophthalmic Disease Therapeutic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Ophthalmic Disease Therapeutic Players in 2022
Table 12. World Ophthalmic Disease Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Ophthalmic Disease Therapeutic Company Evaluation Quadrant
Table 14. Head Office of Key Ophthalmic Disease Therapeutic Player
Table 15. Ophthalmic Disease Therapeutic Market: Company Product Type Footprint
Table 16. Ophthalmic Disease Therapeutic Market: Company Product Application Footprint
Table 17. Ophthalmic Disease Therapeutic Mergers & Acquisitions Activity
Table 18. United States VS China Ophthalmic Disease Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Ophthalmic Disease Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 23. China Based Ophthalmic Disease Therapeutic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Ophthalmic Disease Therapeutic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Ophthalmic Disease Therapeutic Revenue Market Share (2018-2023)
Table 29. World Ophthalmic Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Ophthalmic Disease Therapeutic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Ophthalmic Disease Therapeutic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Ophthalmic Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Ophthalmic Disease Therapeutic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Ophthalmic Disease Therapeutic Market Size by Application (2024-2029) & (USD Million)
Table 35. Regeneron Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Regeneron Pharmaceuticals Major Business
Table 37. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Product and Services
Table 38. Regeneron Pharmaceuticals Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Regeneron Pharmaceuticals Recent Developments/Updates
Table 40. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. AbbVie Inc Basic Information, Area Served and Competitors
Table 42. AbbVie Inc Major Business
Table 43. AbbVie Inc Ophthalmic Disease Therapeutic Product and Services
Table 44. AbbVie Inc Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AbbVie Inc Recent Developments/Updates
Table 46. AbbVie Inc Competitive Strengths & Weaknesses
Table 47. Santen Pharmaceutical Co. Ltd. Basic Information, Area Served and Competitors
Table 48. Santen Pharmaceutical Co. Ltd. Major Business
Table 49. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Product and Services
Table 50. Santen Pharmaceutical Co. Ltd. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Santen Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 52. Santen Pharmaceutical Co. Ltd. Competitive Strengths & Weaknesses
Table 53. Novartis AG Basic Information, Area Served and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Ophthalmic Disease Therapeutic Product and Services
Table 56. Novartis AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Novartis AG Competitive Strengths & Weaknesses
Table 59. Bayer AG Basic Information, Area Served and Competitors
Table 60. Bayer AG Major Business
Table 61. Bayer AG Ophthalmic Disease Therapeutic Product and Services
Table 62. Bayer AG Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bayer AG Recent Developments/Updates
Table 64. Bayer AG Competitive Strengths & Weaknesses
Table 65. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 66. F. Hoffmann-La Roche Major Business
Table 67. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Product and Services
Table 68. F. Hoffmann-La Roche Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. F. Hoffmann-La Roche Recent Developments/Updates
Table 70. Viatris Inc. Basic Information, Area Served and Competitors
Table 71. Viatris Inc. Major Business
Table 72. Viatris Inc. Ophthalmic Disease Therapeutic Product and Services
Table 73. Viatris Inc. Ophthalmic Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Ophthalmic Disease Therapeutic Upstream (Raw Materials)
Table 75. Ophthalmic Disease Therapeutic Typical Customers
LIST OF FIGURES
Figure 1. Ophthalmic Disease Therapeutic Picture
Figure 2. World Ophthalmic Disease Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Ophthalmic Disease Therapeutic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 13. Ophthalmic Disease Therapeutic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Ophthalmic Disease Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Ophthalmic Disease Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Ophthalmic Disease Therapeutic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Ophthalmic Disease Therapeutic Markets in 2022
Figure 27. United States VS China: Ophthalmic Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Ophthalmic Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Ophthalmic Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Ophthalmic Disease Therapeutic Market Size Market Share by Type in 2022
Figure 31. Anti-inflammatory
Figure 32. Anti-infectives
Figure 33. Anti-VEGF
Figure 34. Anti-glaucoma
Figure 35. World Ophthalmic Disease Therapeutic Market Size Market Share by Type (2018-2029)
Figure 36. World Ophthalmic Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Ophthalmic Disease Therapeutic Market Size Market Share by Application in 2022
Figure 38. Glaucoma
Figure 39. Dry Eye Disease
Figure 40. Retinal Diseases
Figure 41. Allergy & Infections
Figure 42. Ophthalmic Disease Therapeutic Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Ophthalmic Disease Therapeutic Picture
Figure 2. World Ophthalmic Disease Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Ophthalmic Disease Therapeutic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Ophthalmic Disease Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Ophthalmic Disease Therapeutic Revenue (2018-2029) & (USD Million)
Figure 13. Ophthalmic Disease Therapeutic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Ophthalmic Disease Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Ophthalmic Disease Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Ophthalmic Disease Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Ophthalmic Disease Therapeutic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Ophthalmic Disease Therapeutic Markets in 2022
Figure 27. United States VS China: Ophthalmic Disease Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Ophthalmic Disease Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Ophthalmic Disease Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Ophthalmic Disease Therapeutic Market Size Market Share by Type in 2022
Figure 31. Anti-inflammatory
Figure 32. Anti-infectives
Figure 33. Anti-VEGF
Figure 34. Anti-glaucoma
Figure 35. World Ophthalmic Disease Therapeutic Market Size Market Share by Type (2018-2029)
Figure 36. World Ophthalmic Disease Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Ophthalmic Disease Therapeutic Market Size Market Share by Application in 2022
Figure 38. Glaucoma
Figure 39. Dry Eye Disease
Figure 40. Retinal Diseases
Figure 41. Allergy & Infections
Figure 42. Ophthalmic Disease Therapeutic Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
